Open Actively Recruiting

Combined Conventional and Ultrafast MRI-Based Integrated Radiomic Models for Predicting Response to Neoadjuvant Chemotherapy in Women with Triple Negative Breast Cancer

About

Brief Summary

This study has not yet been registered on ClinicalTrials.gov, which is currently a pre-requisite for display of detailed eligibility criteria.

Phase
Pilot/Feasibility

Eligibility

Minimum Age
N/A
Maximum Age
N/A

Join this Trial

Contact our clinical trial navigators for opportunities that may be suitable for you
Share:
Study Stats
Protocol No.
20-001080
Category
Breast Cancer
Principal Investigator
KYUNG SUNG
Contact
Victoria Rueda
Location
  • UCLA Westwood